ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

ISIN: BE0974260896-XBRU Updated at

Prev close
Open
Volume
52wk Range
Capitalization

Latest financial news

Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop Next-Generation Allogeneic CAR-T Therapies

Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop Next-Generation Allogeneic CAR-T Therapies

Transparency notification of Victory Capital Management Inc. (Article 14 of the Law of 2 May 2007)

Transparency notification of Victory Capital Management Inc. (Article 14 of the Law of 2 May 2007)

Celyad appoints Carri Duncan as Vice-President Corporate Development & Communications

Celyad appoints Carri Duncan as Vice-President Corporate Development & Communications

Celyad to Participate at Upcoming Healthcare Conferences

Celyad to Participate at Upcoming Healthcare Conferences

Discover all financial news

Investor's kit

Annual Report 2017

Annual Report 2017

Celyad interim financial report H1 2018

Celyad interim financial report H1 2018

Celyad's investors presentation

Celyad's investors presentation

Financial Calendar

November 19, 2018

Q3 2018 Business Update

Want to see more?

Know more about our regulated information